Laddar...
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
The ability to elicit robust and long-term transgene expression in vivo together with minimal immunogenicity and little to no toxicity are only a few features that make recombinant adeno-associated virus (rAAV) vectors ideally suited for many gene therapy applications. Successful preclinical studies...
Sparad:
| I publikationen: | Mol Ther Methods Clin Dev |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4804725/ https://ncbi.nlm.nih.gov/pubmed/27014711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2016.2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|